CliffBio
small molecule

CYPROHEPTADINE HYDROCHLORIDE

CYPROHEPTADINE HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyTris. →See this company's full patent-cliff portfolio

Drug detail

Brand nameCYPROHEPTADINE HYDROCHLORIDE
Active ingredientCYPROHEPTADINE HYDROCHLORIDE
Strength2MG/5ML
Dosage formSYRUP
RouteORAL
ModalitySmall molecule
FDA approvalDecember 2021
Marketing statusDISCN

More from Tris.

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

CYPROHEPTADINE HYDROCHLORIDE patent cliff — loss of exclusivity — | CliffBio